Gene expression profiling of CEBPA double-, single-mutant and CEBPA wild type AML
收藏官方服务：
资源简介：
Gene expression profiling of CEBPA double-, single-mutant and CEBPA wild type AML
应用场景：
创建时间：
2011-08-03
相关数据集
The transcriptome profile of MOSJ-Dkk1 cells treating with DkkMo in vitro and in vivo.
Next-generation sequencing (NGS) has revolutionized the systems-based analysis of cellular pathways. Our aim is to use RNA-seq to reveal the mechanisms by which DkkMo suppresses tumor expansion both i
NIAID Data Ecosystem70
Expression data from 87 complex sarcomas
Based on the transcriptome analysis of 555 sarcomas, we identified a group of tightly clustered leiomyosarcomas (LMS) due to their gene expression homogeneity. We named them “hLMS” and the other LMS “
NIAID Data Ecosystem40
Table_6_Transcriptomic Profiling of Fibropapillomatosis in Green Sea Turtles (Chelonia mydas) From South Texas.csv
Sea turtle fibropapillomatosis (FP) is a tumor promoting disease that is one of several threats globally to endangered sea turtle populations. The prevalence of FP is highest in green sea turtle (Chel
NIAID Data Ecosystem30
Gene expression profiling of CEBPA double and single mutant and CEBPA wild type AML.
Mutations in CCAAT/enhancer binding protein alpha (CEBPA) are seen in 5-14% of acute myeloid leukemia (AML) and have been associated with a favorable clinical outcome. Most AMLs with CEBPA mutations s
NIAID Data Ecosystem40
RNAseq and the histone acetylated chromosome immunoprecipitation of U87 or GBM stem cells(GSC) treated with bulk control/0.5mM 8-cpt-cAMP/1nM MS275 or a combination. RNAseq and the histone acetylated chromosome immunoprecipitation of U87 or GBM stem cells(GSC) treated with bulk control/0.5mM 8-cpt-cAMP/1nM MS275 or a combination
Transcriptomics and the ChIP-seq revealed that the combination of 8-cpt-cAMP and MS275 could maximize the glioma differentation compared to control or use either drug alone Overall design: U87 cells/G
NIAID Data Ecosystem30
